ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00337376
Recruitment Status : Terminated
First Posted : June 15, 2006
Last Update Posted : January 14, 2014
Sponsor:
Collaborator:
Celgene Corporation
Information provided by (Responsible Party):
Maysa Abu-Khalaf, Yale University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : July 2010
  Actual Study Completion Date : July 2010